Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 17, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

1.1K

Managing Clinical N1 Prostate Cancer.

Saeed Imam1, Bertram Yuh1

  • 1Department of Surgery, City of Hope National Cancer Center, 1500 E Duarte Road, Duarte, CA 91010, USA.

The Urologic Clinics of North America
|April 15, 2026
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International Delphi consensus on single-port robotic radical prostatectomy: patient selection, surgical technique, and training.

BJU international·2026
Same author

Feasibility and Preliminary Outcomes of the Modified Makuuchi Incision in Urologic Oncology: A Single-Surgeon Case Series.

Cureus·2026
Same author

Single Port Robotic Radical Prostatectomy: A Propensity-matched Comparison of Transvesical Versus Extraperitoneal Approaches from the Single Port Advanced Research Consortium.

European urology oncology·2026
Same author

Disparities in Outcomes in Latino Subpopulations with Localized Prostate Cancer Undergoing Radical Prostatectomy: A Population-Based Analysis.

Cancers·2026
Same author

Single-port Robotic Retroperitoneal Partial Nephrectomy via Low Anterior Access: A Propensity-matched Comparative Analysis to Standard Transperitoneal Multiport Robotic Surgery from the Single Port Advanced Research Consortium (SPARC).

European urology focus·2025
Same author

Low incidence of venous thromboembolic complications following single-port robotic surgeries for upper and lower tract urological malignancies: a report from the Single-Port Advanced Research Consortium (SPARC).

Journal of robotic surgery·2025
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Clinical lymph node positive prostate cancer involves aggressive prostate adenocarcinoma spreading to lymph nodes. Diagnosis requires careful imaging, and treatment is multimodal, often including surgery, radiation, and hormone therapy for optimal outcomes.

Area of Science:

  • Oncology
  • Urology
  • Medical Imaging

Background:

  • Clinical lymph node positive prostate cancer is prostate adenocarcinoma with regional lymph node metastasis.
  • This condition represents an aggressive cancer with variable prognosis and presentation.
  • Accurate staging is crucial to differentiate from distant metastatic disease.

Purpose of the Study:

  • To summarize the diagnostic and therapeutic strategies for clinical lymph node positive prostate cancer.
  • To emphasize the importance of diagnostic imaging in staging.
  • To highlight the role of multimodal treatment approaches.

Main Methods:

  • Review of diagnostic imaging techniques for lymph node staging.
  • Analysis of multimodal treatment options including surgery, radiation, and hormone therapy.
Keywords:
Node positiveProstate cancercN1

More Related Videos

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

10.0K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.0K

Related Experiment Videos

Last Updated: Apr 17, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

1.1K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

10.0K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.0K
  • Discussion of treatment individualization based on patient factors.

    • Main Results:

    • Diagnostic imaging is critical for accurate staging of lymph node positive prostate cancer.
    • Multimodal therapy, combining surgery and/or radiation with hormone therapy, is the standard of care.
    • Androgen deprivation therapy is a key component in both surgical and radiation-based strategies.

    Conclusions:

    • Clinical lymph node positive prostate cancer requires precise diagnosis and individualized multimodal treatment.
    • Effective management relies on accurate staging and combining therapeutic modalities like surgery, radiation, and hormone therapy.
    • Treatment strategies should be tailored to optimize outcomes for this aggressive cancer.